Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Sulfonamides"" wg kryterium: Wszystkie pola

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 81391

Starter badań:

Tytuł:
Preparation of COPs Mixed Matrix Membrane for Sensitive Determination of Six Sulfonamides in Human Urine.
Autorzy:
Liu Y; School of Pharmacy, Jining Medical University, Rizhao 276826, China.
Zhang Y; School of Pharmacy, Jining Medical University, Rizhao 276826, China.
Wang J; School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Wang K; School of Pharmacy, Jining Medical University, Rizhao 276826, China.
Gao S; School of Pharmacy, Jining Medical University, Rizhao 276826, China.
Cui R; School of Pharmacy, Jining Medical University, Rizhao 276826, China.
Liu F; School of Pharmacy, Jining Medical University, Rizhao 276826, China.
Gao G; School of Pharmacy, Jining Medical University, Rizhao 276826, China.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Oct 30; Vol. 28 (21). Date of Electronic Publication: 2023 Oct 30.
Typ publikacji:
Journal Article
MeSH Terms:
Polymers*/analysis
Sulfonamides*/analysis
Humans ; Solid Phase Extraction/methods ; Chromatography, High Pressure Liquid ; Limit of Detection
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pyrazolo[4,3- e ]tetrazolo[1,5- b ][1,2,4]triazine Sulfonamides as Novel Potential Anticancer Agents: Apoptosis, Oxidative Stress, and Cell Cycle Analysis.
Autorzy:
Bukowski K; Department of Molecular Biotechnology and Genetics, University of Lodz, 90-237 Lodz, Poland.
Marciniak B; Department of Molecular Biotechnology and Genetics, University of Lodz, 90-237 Lodz, Poland.
Kciuk M; Department of Molecular Biotechnology and Genetics, University of Lodz, 90-237 Lodz, Poland.; Doctoral School of Exact and Natural Sciences, University of Lodz, 90-237 Lodz, Poland.
Mujwar S; Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India.
Mojzych M; Department of Chemistry, Siedlce University of Natural Sciences and Humanities, 08-110 Siedlce, Poland.
Kontek R; Department of Molecular Biotechnology and Genetics, University of Lodz, 90-237 Lodz, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 May 09; Vol. 24 (10). Date of Electronic Publication: 2023 May 09.
Typ publikacji:
Journal Article
MeSH Terms:
Sulfonamides*/pharmacology
Sulfonamides*/chemistry
Antineoplastic Agents*/chemistry
Humans ; Molecular Structure ; HeLa Cells ; Triazines/pharmacology ; Triazines/chemistry ; Drug Screening Assays, Antitumor ; Cell Cycle Checkpoints ; Oxidative Stress ; Sulfanilamide/pharmacology ; Apoptosis ; Cell Proliferation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial.
Autorzy:
Chen C; Graduate School, Hainan Medical University, Haikou, 571199, China.
Zhang D; Graduate School, Hainan Medical University, Haikou, 571199, China.
Huang S; Graduate School, Hainan Medical University, Haikou, 571199, China.
Zeng F; Graduate School, Hainan Medical University, Haikou, 571199, China.
Li D; Graduate School, Hainan Medical University, Haikou, 571199, China.
Zhang X; Graduate School, Hainan Medical University, Haikou, 571199, China.
Chen R; Graduate School, Hainan Medical University, Haikou, 571199, China.
Chen S; Graduate School, Hainan Medical University, Haikou, 571199, China.
Wang J; Department of Gastroenterology, The 986 Hospital of Xijing Hospital, Air Force Military Medical University, Xi'an, 710054, Shanxi, China. .
Bai F; Department of Gastroenterology, The Second Affiliated Hospital of Hainan Medical University, Yehai Avenue, #368, Longhua District, Haikou, 570216, Hainan Province, China. baifeihu_.; The Gastroenterology Clinical Medical Center of Hainan Province, Haikou, 570216, China. baifeihu_.
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2024 Apr 12; Vol. 24 (1), pp. 131. Date of Electronic Publication: 2024 Apr 12.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Helicobacter Infections*/drug therapy
Helicobacter pylori*
Pyrroles*
Sulfonamides*
Humans ; Bismuth/therapeutic use ; Furazolidone/therapeutic use ; Amoxicillin/therapeutic use ; Citrates
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Differential Effect of Senolytics on SASP Cytokine Secretion and Regulation of EMT by CAFs.
Autorzy:
Bogdanova DA; Division of Immunobiology and Biomedicine, Sirius University of Science and Technology, Sirius, Krasndarsky Krai, 354340 Sochi, Russia.; Institute of Cytology RAS, 194064 St. Petersburg, Russia.
Kolosova ED; Institute of Cytology RAS, 194064 St. Petersburg, Russia.
Pukhalskaia TV; Division of Immunobiology and Biomedicine, Sirius University of Science and Technology, Sirius, Krasndarsky Krai, 354340 Sochi, Russia.; Institute of Cytology RAS, 194064 St. Petersburg, Russia.
Levchuk KA; World-Class Research Centre for Personalized Medicine, Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.
Demidov ON; Division of Immunobiology and Biomedicine, Sirius University of Science and Technology, Sirius, Krasndarsky Krai, 354340 Sochi, Russia.; Institute of Cytology RAS, 194064 St. Petersburg, Russia.; INSERM UMR1231, University of Burgundy, 21078 Dijon, France.
Belotserkovskaya EV; Institute of Cytology RAS, 194064 St. Petersburg, Russia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Apr 04; Vol. 25 (7). Date of Electronic Publication: 2024 Apr 04.
Typ publikacji:
Journal Article
MeSH Terms:
Senotherapeutics*
Cancer-Associated Fibroblasts*
Aniline Compounds*
Sulfonamides*
Humans ; Dasatinib/pharmacology ; Quercetin/pharmacology ; Carcinogenesis ; Cell Transformation, Neoplastic ; Epithelial-Mesenchymal Transition ; Cytokines ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1.
Autorzy:
Zhao K; Department of Neurosurgery, Philipps University Marburg, Baldingerstraße 1, 35043 Marburg, Germany.; Department of Hematology, Oncology & Immunology, Philipps University Marburg, Baldingerstraße 1, 35043 Marburg, Germany.
Braun M; Department of Neurosurgery, Philipps University Marburg, Baldingerstraße 1, 35043 Marburg, Germany.; Department of Hematology, Oncology & Immunology, Philipps University Marburg, Baldingerstraße 1, 35043 Marburg, Germany.
Meyer L; Department of Neurosurgery, Philipps University Marburg, Baldingerstraße 1, 35043 Marburg, Germany.; Department of Hematology, Oncology & Immunology, Philipps University Marburg, Baldingerstraße 1, 35043 Marburg, Germany.
Otte K; Department of Neurosurgery, Philipps University Marburg, Baldingerstraße 1, 35043 Marburg, Germany.; Department of Hematology, Oncology & Immunology, Philipps University Marburg, Baldingerstraße 1, 35043 Marburg, Germany.
Raifer H; FACS Core Facility, Philipps University Marburg, Hans-Meerwein-Straße 3, 35043 Marburg, Germany.
Helmprobst F; Department of Neuropathology, Philipps University Marburg, Baldingerstraße 1, 35043 Marburg, Germany.
Möschl V; Department of Neuropathology, Philipps University Marburg, Baldingerstraße 1, 35043 Marburg, Germany.
Pagenstecher A; Department of Neuropathology, Philipps University Marburg, Baldingerstraße 1, 35043 Marburg, Germany.; University Cancer Center (UCT) Frankfurt-Marburg, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.
Urban H; University Cancer Center (UCT) Frankfurt-Marburg, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.; Dr. Senckenberg Institute of Neurooncology, Goethe-University of Frankfurt, Schleusenweg 2-16, 60528 Frankfurt am Main, Germany.
Ronellenfitsch MW; University Cancer Center (UCT) Frankfurt-Marburg, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.; Dr. Senckenberg Institute of Neurooncology, Goethe-University of Frankfurt, Schleusenweg 2-16, 60528 Frankfurt am Main, Germany.
Steinbach JP; University Cancer Center (UCT) Frankfurt-Marburg, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.; Dr. Senckenberg Institute of Neurooncology, Goethe-University of Frankfurt, Schleusenweg 2-16, 60528 Frankfurt am Main, Germany.
Pesek J; Medical Mass Spectrometry Core Facility, Philipps University Marburg, Baldingerstraße 1, 35043 Marburg, Germany.
Watzer B; Medical Mass Spectrometry Core Facility, Philipps University Marburg, Baldingerstraße 1, 35043 Marburg, Germany.
Nockher WA; Medical Mass Spectrometry Core Facility, Philipps University Marburg, Baldingerstraße 1, 35043 Marburg, Germany.
Taudte RV; Medical Mass Spectrometry Core Facility, Philipps University Marburg, Baldingerstraße 1, 35043 Marburg, Germany.
Neubauer A; Department of Hematology, Oncology & Immunology, Philipps University Marburg, Baldingerstraße 1, 35043 Marburg, Germany.; University Cancer Center (UCT) Frankfurt-Marburg, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.
Nimsky C; Department of Neurosurgery, Philipps University Marburg, Baldingerstraße 1, 35043 Marburg, Germany.; University Cancer Center (UCT) Frankfurt-Marburg, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.
Bartsch JW; Department of Neurosurgery, Philipps University Marburg, Baldingerstraße 1, 35043 Marburg, Germany.; University Cancer Center (UCT) Frankfurt-Marburg, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.
Rusch T; Department of Hematology, Oncology & Immunology, Philipps University Marburg, Baldingerstraße 1, 35043 Marburg, Germany.; University Cancer Center (UCT) Frankfurt-Marburg, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Apr 04; Vol. 13 (7). Date of Electronic Publication: 2024 Apr 04.
Typ publikacji:
Journal Article
MeSH Terms:
Glioblastoma*/drug therapy
Glioblastoma*/metabolism
Antineoplastic Agents*/pharmacology
Amides*
Pyrimidines*
Sulfonamides*
Bridged Bicyclo Compounds, Heterocyclic*
Animals ; Mice ; Temozolomide/pharmacology ; Methotrexate/pharmacology ; Methotrexate/therapeutic use ; Cytarabine/pharmacology ; Cytarabine/therapeutic use ; Antineoplastic Agents, Alkylating/pharmacology ; Cell Line, Tumor ; Apoptosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effectiveness and safety of baricitinib in patients with moderate-to-severe refractory alopecia areata in real world: An open-label, single-center study.
Autorzy:
Bi L; Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Wang C; Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Du Y; Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Su T; Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; Department of Dermatology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China.
Zhao M; Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Lin X; Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Fan W; Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Sun W; Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Pokaż więcej
Źródło:
Journal of cosmetic dermatology [J Cosmet Dermatol] 2024 Apr; Vol. 23 (4), pp. 1417-1421. Date of Electronic Publication: 2023 Dec 20.
Typ publikacji:
Journal Article
MeSH Terms:
Alopecia Areata*/drug therapy
Janus Kinase Inhibitors*/adverse effects
Azetidines*
Purines*
Pyrazoles*
Sulfonamides*
Male ; Female ; Humans ; Retrospective Studies ; Immunoglobulin A/therapeutic use
SCR Disease Name:
Diffuse alopecia
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Wnt5a/β-catenin-mediated epithelial-mesenchymal transition: a key driver of subretinal fibrosis in neovascular age-related macular degeneration.
Autorzy:
Liu D; Department of Ophthalmology of Tongji Hospital and Laboratory of Clinical and Visual Sciences of Tongji Eye Institute, School of Medicine, Tongji University, Shanghai, China.
Du J; Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai Key Laboratory of Ocular Fundus Diseases, National Clinical Research Center for Eye Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai Eye Research Institute, Shanghai, China.
Xie H; Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai Key Laboratory of Ocular Fundus Diseases, National Clinical Research Center for Eye Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai Eye Research Institute, Shanghai, China.
Tian H; Department of Ophthalmology of Tongji Hospital and Laboratory of Clinical and Visual Sciences of Tongji Eye Institute, School of Medicine, Tongji University, Shanghai, China.
Lu L; Department of Ophthalmology of Tongji Hospital and Laboratory of Clinical and Visual Sciences of Tongji Eye Institute, School of Medicine, Tongji University, Shanghai, China.
Zhang C; Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, China. .; Shanghai Key Laboratory of Ocular Fundus Diseases, National Clinical Research Center for Eye Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai Eye Research Institute, Shanghai, China. .
Xu GT; Department of Ophthalmology of Tongji Hospital and Laboratory of Clinical and Visual Sciences of Tongji Eye Institute, School of Medicine, Tongji University, Shanghai, China. .
Zhang J; Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, China. .; Shanghai Key Laboratory of Ocular Fundus Diseases, National Clinical Research Center for Eye Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai Eye Research Institute, Shanghai, China. .
Pokaż więcej
Źródło:
Journal of neuroinflammation [J Neuroinflammation] 2024 Mar 26; Vol. 21 (1), pp. 75. Date of Electronic Publication: 2024 Mar 26.
Typ publikacji:
Journal Article
MeSH Terms:
beta Catenin*/metabolism
Macular Degeneration*/metabolism
Sulfonamides*
Humans ; Male ; Animals ; Mice ; Wnt-5a Protein ; Mice, Inbred C57BL ; Retinal Pigment Epithelium/metabolism ; Epithelial-Mesenchymal Transition ; Fibrosis ; RNA, Small Interfering/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
IRF1 Mediates Growth Arrest and the Induction of a Secretory Phenotype in Alveolar Epithelial Cells in Response to Inflammatory Cytokines IFNγ/TNFα.
Autorzy:
Recchia Luciani G; Laboratory of General Pathology, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.
Barilli A; Laboratory of General Pathology, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.
Visigalli R; Laboratory of General Pathology, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.
Sala R; Laboratory of General Pathology, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.
Dall'Asta V; Laboratory of General Pathology, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.
Rotoli BM; Laboratory of General Pathology, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 19; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 19.
Typ publikacji:
Journal Article
MeSH Terms:
Azetidines*
Cytokines*/metabolism
Purines*
Pyrazoles*
Sulfonamides*
Tumor Necrosis Factor-alpha*/metabolism
Alveolar Epithelial Cells/metabolism ; Cellular Senescence ; Interleukin-6/metabolism ; Phenotype ; A549 Cells ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
PROTAC-Mediated Dual Degradation of BCL-xL and BCL-2 Is a Highly Effective Therapeutic Strategy in Small-Cell Lung Cancer.
Autorzy:
Khan S; Department of Biochemistry & Structural Biology, Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.; Mays Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Cao L; Department of Biochemistry & Structural Biology, Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Wiegand J; Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA.
Zhang P; Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA.
Zajac-Kaye M; Department of Anatomy & Cell Biology, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
Kaye FJ; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
Zheng G; Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA.
Zhou D; Department of Biochemistry & Structural Biology, Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.; Mays Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Mar 17; Vol. 13 (6). Date of Electronic Publication: 2024 Mar 17.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/drug therapy
Small Cell Lung Carcinoma*/pathology
Antineoplastic Agents*/pharmacology
Thrombocytopenia*
Aniline Compounds*
Sulfonamides*
Bridged Bicyclo Compounds, Heterocyclic*
Humans ; Mice ; Animals ; bcl-X Protein/metabolism ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Disease Models, Animal
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Steroid-Induced Ocular Hypertension in Mice Is Differentially Reduced by Selective EP2, EP3, EP4, and IP Prostanoid Receptor Agonists.
Autorzy:
Sharif NA; Ophthalmology Innovation Center, Santen Inc., Emeryville, CA 94608, USA.; Institute of Ophthalmology, University College London (UCL), London EC1V 9EL, UK.; Department of Ophthalmology, Imperial College of Science and Technology, St. Mary's Campus, London W2 1PG, UK.; Department of Ophthalmology, Eye-ACP Duke-National University of Singapore Medical School, Singapore 119228, Singapore.; Singapore Eye Research Institute (SERI), Singapore 168751, Singapore.; Department of Pharmacy Sciences, Creighton University, Omaha, NE 68178, USA.; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX 77004, USA.; Department of Pharmacology & Neuroscience, North Texas Eye Research Institute (NTERI), University of North Texas Health Science Center, Fort Worth, TX 76107, USA.
Millar JC; Department of Pharmacology & Neuroscience, North Texas Eye Research Institute (NTERI), University of North Texas Health Science Center, Fort Worth, TX 76107, USA.
Zode G; Department of Ophthalmology and Center for Translational Vision Research, University of California, Irvine, CA 92617, USA.
Ota T; Ophthalmology Innovation Center, Santen Pharmaceutical Co., Ltd., Nara 630-0101, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 15; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 15.
Typ publikacji:
Journal Article
MeSH Terms:
Misoprostol*/pharmacology
Misoprostol*/therapeutic use
Ocular Hypertension*/chemically induced
Ocular Hypertension*/drug therapy
Acetamides*
Acetates*
Pyrazines*
Sulfonamides*
Animals ; Mice ; Tissue Plasminogen Activator ; Receptors, Prostaglandin ; Receptors, Prostaglandin E, EP4 Subtype ; Steroids
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of vonoprazan and proton pump inhibitors for the treatment of gastric endoscopic submucosal dissection-induced ulcer: an updated systematic review and meta-analysis.
Autorzy:
Chen L; Department of Infectious Disease, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, Shandong, China.
Jiang D; Department of Gastroenterology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, Shandong, China.
Hu D; Department of Gastroenterology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, Shandong, China.
Cui X; Department of Gastroenterology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, Shandong, China. .
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2024 Mar 15; Vol. 24 (1), pp. 110. Date of Electronic Publication: 2024 Mar 15.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Stomach Ulcer*/drug therapy
Stomach Ulcer*/etiology
Stomach Ulcer*/surgery
Endoscopic Mucosal Resection*/adverse effects
Endoscopic Mucosal Resection*/methods
Stomach Neoplasms*/surgery
Pyrroles*
Sulfonamides*
Humans ; Proton Pump Inhibitors/therapeutic use ; Ulcer/drug therapy ; Ulcer/etiology ; Postoperative Hemorrhage ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Rare Case of Recurrent Adamantinoma of the Tibia: Limited Efficacy of Pazopanib as a Standalone Treatment.
Autorzy:
Elshenawy M; Department of Medical Oncology, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt.
Aldahoul SK; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
El-Sibai AM; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Hamad A; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Arabi TZ; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Abdul Rab S; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Badran A; Department of Medical Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Alzaid T; Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Sabbah BN; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Atallah JP; Department of Medical Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2024 Mar 15; Vol. 25, pp. e941248. Date of Electronic Publication: 2024 Mar 15.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Adamantinoma*/pathology
Adamantinoma*/secondary
Adamantinoma*/surgery
Bone Neoplasms*/pathology
Ameloblastoma*/complications
Ameloblastoma*/pathology
Ameloblastoma*/surgery
Indazoles*
Pyrimidines*
Sulfonamides*
Female ; Humans ; Young Adult ; Adult ; Tibia/surgery
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Topical netarsudil for the treatment of primary corneal endothelial degeneration in dogs.
Autorzy:
Casanova MI; Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, 1 Shields Ave., Davis, CA, 95616, USA.
Park S; Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, 1 Shields Ave., Davis, CA, 95616, USA.
Mayes MA; William R. Pritchard Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California Davis, Davis, CA, 95161, USA.
Roszak K; Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, 1 Shields Ave., Davis, CA, 95616, USA.
Ferneding M; Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, 1 Shields Ave., Davis, CA, 95616, USA.
Echeverria N; Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, 1 Shields Ave., Davis, CA, 95616, USA.
Bowman MAW; Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, 1 Shields Ave., Davis, CA, 95616, USA.
Michalak SR; Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, 1 Shields Ave., Davis, CA, 95616, USA.
Ardon M; Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, 1 Shields Ave., Davis, CA, 95616, USA.
Wong S; Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, 1 Shields Ave., Davis, CA, 95616, USA.
Le SM; Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, 1 Shields Ave., Davis, CA, 95616, USA.
Daley N; Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, 1 Shields Ave., Davis, CA, 95616, USA.
Leonard BC; Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, 1 Shields Ave., Davis, CA, 95616, USA.
Good KL; Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, 1 Shields Ave., Davis, CA, 95616, USA.
Li JY; Department of Ophthalmology and Vision Science, School of Medicine, University of California Davis, Davis, CA, 95616, USA.
Thomasy SM; Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, 1 Shields Ave., Davis, CA, 95616, USA. .; Department of Ophthalmology and Vision Science, School of Medicine, University of California Davis, Davis, CA, 95616, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 14; Vol. 14 (1), pp. 6238. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Corneal Edema*/drug therapy
Corneal Dystrophies, Hereditary*
Benzoates*
Isoquinolines*
Sulfonamides*
beta-Alanine/*analogs & derivatives
Humans ; Dogs ; Animals ; Prospective Studies ; Disease Progression ; Ophthalmic Solutions/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
C/EBPα-p30 confers AML cell susceptibility to the terminal unfolded protein response and resistance to Venetoclax by activating DDIT3 transcription.
Autorzy:
Du M; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Rd., Hangzhou, 310003, Zhejiang Province, People's Republic of China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
Wang M; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Rd., Hangzhou, 310003, Zhejiang Province, People's Republic of China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
Liu M; Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center, Duarte, CA, USA.
Fu S; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Rd., Hangzhou, 310003, Zhejiang Province, People's Republic of China.
Lin Y; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Rd., Hangzhou, 310003, Zhejiang Province, People's Republic of China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
Huo Y; Hematology Department, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe Dong Rd., Zhengzhou, 450000, Henan Province, People's Republic of China.
Yu J; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Rd., Hangzhou, 310003, Zhejiang Province, People's Republic of China.; Institute of Hematology, Zhejiang University, Hangzhou, China.
Yu X; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
Wang C; Hematology Department, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe Dong Rd., Zhengzhou, 450000, Henan Province, People's Republic of China. .
Xiao H; Department of Hematology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. .; Institute of Hematology, Zhejiang University, Hangzhou, China. .; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China. .
Wang L; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Rd., Hangzhou, 310003, Zhejiang Province, People's Republic of China. .; Institute of Hematology, Zhejiang University, Hangzhou, China. .; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Mar 13; Vol. 43 (1), pp. 79. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents*/therapeutic use
Bridged Bicyclo Compounds, Heterocyclic*
Leukemia, Myeloid, Acute*/metabolism
Sulfonamides*
Animals ; Humans ; Mice ; CCAAT-Enhancer-Binding Protein-alpha/genetics ; CCAAT-Enhancer-Binding Protein-alpha/metabolism ; CCAAT-Enhancer-Binding Protein-alpha/therapeutic use ; Protein Isoforms ; Proto-Oncogene Proteins c-bcl-2/genetics ; Transcription Factor CHOP/genetics ; Unfolded Protein Response
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ripasudil as a Potential Therapeutic Agent in Treating Secondary Glaucoma in HTLV-1-Uveitis: An In Vitro Analysis.
Autorzy:
Yang M; Department of Ophthalmology & Visual Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
Kamoi K; Department of Ophthalmology & Visual Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
Zong Y; Department of Ophthalmology & Visual Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
Zhang J; Department of Ophthalmology & Visual Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
Zou Y; Department of Ophthalmology & Visual Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
Ohno-Matsui K; Department of Ophthalmology & Visual Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 12; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:
Journal Article
MeSH Terms:
Human T-lymphotropic virus 1*
Glaucoma*/drug therapy
Glaucoma*/etiology
Uveitis*
Isoquinolines*
Sulfonamides*
Adult ; Humans ; NF-kappa B ; Cytokines/therapeutic use ; Interleukin-6 ; rho-Associated Kinases
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Electrolyte disorders induced by six multikinase inhibitors therapy for renal cell carcinoma: a large-scale pharmacovigilance analysis.
Autorzy:
She X; Department of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
Yin D; Department of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
Guo Q; Department of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
Tang Y; Department of Pharmacy, School of Pharmacy, Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
Wang S; Department of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China. .
Wang X; Central Laboratory, Shanxi Hospital of Integrated Traditional Chinese and Western Medicine, Taiyuan, Shanxi, People's Republic of China. .; Key Laboratory of Research and Development of Traditional Chinese Medicine Preparations, Taiyuan, Shanxi, People's Republic of China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 07; Vol. 14 (1), pp. 5592. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Anilides*
Carcinoma, Renal Cell*/drug therapy
Indazoles*
Kidney Neoplasms*/pathology
Phenylurea Compounds*
Pyridines*
Pyrimidines*
Quinolines*
Sulfonamides*
Aged ; Humans ; Male ; Axitinib/therapeutic use ; Bayes Theorem ; Electrolytes ; Pharmacovigilance ; Retrospective Studies ; Sorafenib/adverse effects ; Sunitinib/adverse effects ; United States ; United States Food and Drug Administration ; Female ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Intracerebral hemorrhage-induced brain injury in mice: The role of peroxiredoxin 2-Toll-like receptor 4 inflammatory axis.
Autorzy:
Du Y; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Capital Medical University, Beijing, China.; Laboratory for Clinical Medicine, Capital Medical University, Beijing, China.
Wang J; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Capital Medical University, Beijing, China.; Laboratory for Clinical Medicine, Capital Medical University, Beijing, China.
Zhang J; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Capital Medical University, Beijing, China.; Laboratory for Clinical Medicine, Capital Medical University, Beijing, China.
Li N; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Capital Medical University, Beijing, China.; Laboratory for Clinical Medicine, Capital Medical University, Beijing, China.
Li G; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Capital Medical University, Beijing, China.; Laboratory for Clinical Medicine, Capital Medical University, Beijing, China.
Liu X; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Capital Medical University, Beijing, China.; Laboratory for Clinical Medicine, Capital Medical University, Beijing, China.
Lin Y; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Capital Medical University, Beijing, China.; Laboratory for Clinical Medicine, Capital Medical University, Beijing, China.
Wang D; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Capital Medical University, Beijing, China.; Laboratory for Clinical Medicine, Capital Medical University, Beijing, China.
Kang K; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Capital Medical University, Beijing, China.; Laboratory for Clinical Medicine, Capital Medical University, Beijing, China.
Bian L; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Capital Medical University, Beijing, China.; Laboratory for Clinical Medicine, Capital Medical University, Beijing, China.
Zhao X; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Capital Medical University, Beijing, China.; Laboratory for Clinical Medicine, Capital Medical University, Beijing, China.; Research Unit of Artificial Intelligence in Cerebrovascular Disease, Chinese Academy of Medical Sciences, Beijing, China.; Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.
Pokaż więcej
Źródło:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Mar; Vol. 30 (3), pp. e14681.
Typ publikacji:
Journal Article
MeSH Terms:
Brain Injuries*/etiology
Sulfonamides*
Toll-Like Receptor 4*/metabolism
Animals ; Mice ; Cerebral Hemorrhage/metabolism ; Inflammation/etiology ; Inflammation/pathology ; Mice, Inbred C57BL ; Peroxiredoxins/metabolism ; Peroxiredoxins/pharmacology ; Peroxiredoxins/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 81391

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies